Schonfeld Strategic Advisors LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 256 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,262,699
-80.2%
347,040
-73.6%
0.02%
-80.3%
Q1 2024$11,429,644
+1269.1%
1,312,244
+1698.2%
0.08%
+1166.7%
Q4 2023$834,845
+167.6%
72,976
+125.2%
0.01%
+200.0%
Q3 2023$312,012
-86.7%
32,400
-85.4%
0.00%
-90.0%
Q2 2023$2,354,397
+669.3%
221,278
+795.9%
0.02%
+566.7%
Q4 2022$306,033
-79.8%
24,700
-83.1%
0.00%
-76.9%
Q3 2022$1,517,000
+223.5%
146,563
+264.6%
0.01%
+225.0%
Q4 2021$469,000
-3.1%
40,200
+8.6%
0.00%
-20.0%
Q3 2021$484,000
-20.3%
37,000
-21.5%
0.01%
-16.7%
Q2 2021$607,000
+177.2%
47,118
+117.4%
0.01%
-57.1%
Q1 2020$219,000
+12.3%
21,677
+48.2%
0.01%
+180.0%
Q4 2019$195,000
+107.4%
14,623
+34.2%
0.01%
+66.7%
Q3 2019$94,000
-92.0%
10,900
-85.7%
0.00%
-96.6%
Q1 2018$1,176,000
-17.4%
76,195
+1.0%
0.09%
-40.1%
Q2 2017$1,424,000
-69.7%
75,411
-72.6%
0.15%
-68.9%
Q1 2017$4,704,000
+70.1%
275,712
+52.4%
0.47%
+31.8%
Q4 2016$2,766,000180,8810.36%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$183,240,00017.56%
HealthInvest Partners AB 1,450,000$16,211,00012.91%
Healthcare Value Capital, LLC 200,000$2,236,0004.98%
BRIDGER MANAGEMENT, LLC 2,852,414$31,890,0002.98%
Camber Capital Management LP 7,500,000$83,850,0002.88%
13D Management LLC 658,017$7,357,0002.72%
Brown Capital Management 20,170,126$225,502,0001.68%
Healthcare Value Capital, LLC 50,000$559,0001.24%
Zebra Capital Management LLC 59,122$661,0000.73%
PRICE MICHAEL F 520,000$5,814,0000.70%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders